When prostate cancer cell metastases to the bone, the cancer cell secrete matrix metalloproteinase-9 (MMP-9), urokinase plasminogen activator receptor (uPAR), and cathepsin B (CB), which degrade the bone matrix to release growth factors. Here, PLAUR is linked to prostate carcinoma.